Eli Lilly

The political action committee of Indianapolis-based Eli Lilly, LillyPAC, has joined other major corporations in pausing political donations to some politicians after last week’s insurrection at the capitol. 

Eli Lilly announced a new program Tuesday that caps the out-of-pocket costs for most insulin users at $35 a month. The Indianapolis-based company says it’s designed to help diabetes patients during the novel coronavirus crisis. 

The Lilly Endowment is giving Indiana organizations millions of dollars in grants in response to the novel coronavirus pandemic.

Indianapolis-based Eli Lilly and Company Tuesday expanded free COVID-19 testing to first responders in addition to health care workers.

INDIANAPOLIS (AP) — Five more deaths have been reported in Indiana from the coronavirus-related illness, giving the state a total of 12 as a statewide stay-at-home order is about to take effect.

The Indiana State Department of Health reported Tuesday that the number of confirmed COVID-19 cases grew by 107 to reach a total of 365 across the state.

Six Indiana organizations have pitched in to buy a new high-tech microscope. The nearly $9 million machine is a cryo-electron microscope that allows scientists to examine molecules at the atomic level.

Purdue University Professor of Biological Sciences Richard Kuhn says a sample is taken and immersed in liquid nitrogen. 

President Donald Trump announced the nomination of a former Eli Lilly executive as Health and Human Services Secretary Monday. Alex Azar is the latest Hoosier headed to Washington for a post in the federal health sector.

At Indianapolis-based pharmaceutical giant Eli Lilly, 2,300 employees will take buyouts as part of the company’s effort to save money by cutting at least 2,000 jobs in the U.S. by the end of the year.

It’s unclear whether layoffs are still in the works in the Hoosier state.

Lilly said in September it would aim to save $500 million by cutting 3,500 jobs out of its more than 41,000 worldwide, with at least 2,000 cut in the U.S.

There are reports a former Eli Lilly leader tops the list of names President Donald Trump is considering to fill the position of Health and Human Services Secretary. Alex Azar would replace Tom Price, who left the job last month after a private plane scandal.

Azar would the take over the country’s highest health position if chosen, following a string of others leaving Indiana for the U.S. government’s health sector.

The Indiana University School of Medicine is getting $25 million from the Lilly Endowment to recruit new scientists to Indiana, and to pair them up directly with big Indiana companies.

Medical school research dean Anantha Shekhar says it aims to fast-track the creation of treatments from discoveries about cancer, diabetes, Alzheimer’s and more.

He says new technologies like gene sequencing are facilitating those applications faster than ever.

Eli Lilly is partnering with Pfizer to help develop a new drug that could be the first of a new class of non-opioid pain medications.

There hasn’t been a new pain medication discovery in about 50 years. The last new non-opioid pain medication to hit the market was ibuprofen in the late 1960s.

That’s a problem, because Indiana University Health’s Daniel Rusyniak says when it comes to the treatment of chronic pain we need more options.

Indianapolis-based Eli Lilly has been dealt another blow by the U.S. Food and Drug Administration, which failed to approve a newly-developed treatment for rheumatoid arthritis.

In what is referred to as a “complete response letter,” The FDA stated it wants Lilly to supply more data to clarify safes dosage levels and put certain safety concerns to rest.